Cargando…

Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report

INTRODUCTION: The abscopal effect (AE) is a phenomenon, in which radiotherapy exerts an antitumour effect on distant lesions outside the primary irradiated area. Although immune checkpoint inhibitors have been widely studied for their potential to enhance the AE and improve patient outcomes, finding...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Masashi, Fukuda, Yukiko, Okada, Kouhei, Ogawa, Kazunari, Nakamura, Michiko, Takahashi, Satoru, Kawahara, Masahiro, Akahane, Keiko, Nagai, Yoshiaki, Yamaguchi, Hironori, Nishino, Hiroshi, Mori, Harushi, Shirai, Katsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631779/
https://www.ncbi.nlm.nih.gov/pubmed/37946746
http://dx.doi.org/10.1159/000534609
_version_ 1785132436513882112
author Endo, Masashi
Fukuda, Yukiko
Okada, Kouhei
Ogawa, Kazunari
Nakamura, Michiko
Takahashi, Satoru
Kawahara, Masahiro
Akahane, Keiko
Nagai, Yoshiaki
Yamaguchi, Hironori
Nishino, Hiroshi
Mori, Harushi
Shirai, Katsuyuki
author_facet Endo, Masashi
Fukuda, Yukiko
Okada, Kouhei
Ogawa, Kazunari
Nakamura, Michiko
Takahashi, Satoru
Kawahara, Masahiro
Akahane, Keiko
Nagai, Yoshiaki
Yamaguchi, Hironori
Nishino, Hiroshi
Mori, Harushi
Shirai, Katsuyuki
author_sort Endo, Masashi
collection PubMed
description INTRODUCTION: The abscopal effect (AE) is a phenomenon, in which radiotherapy exerts an antitumour effect on distant lesions outside the primary irradiated area. Although immune checkpoint inhibitors have been widely studied for their potential to enhance the AE and improve patient outcomes, findings in cases of head and neck cancers remain limited. CASE PRESENTATION: We report the case of a 72-year-old man who experienced lung oligoprogression during nivolumab treatment for metastatic hypopharyngeal cancer. Stereotactic body radiotherapy (SBRT) was administered to one of the lung lesions, after which both irradiated and nonirradiated lesions regressed. Upon an 18-month follow-up period after SBRT, the patient showed no disease progression or toxicity, and continued receiving nivolumab therapy. CONCLUSION: The intent behind presenting this case report was to contribute to the accumulation of evidence regarding the AE in cases of head and neck cancer.
format Online
Article
Text
id pubmed-10631779
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-106317792023-11-09 Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report Endo, Masashi Fukuda, Yukiko Okada, Kouhei Ogawa, Kazunari Nakamura, Michiko Takahashi, Satoru Kawahara, Masahiro Akahane, Keiko Nagai, Yoshiaki Yamaguchi, Hironori Nishino, Hiroshi Mori, Harushi Shirai, Katsuyuki Case Rep Oncol Case Report INTRODUCTION: The abscopal effect (AE) is a phenomenon, in which radiotherapy exerts an antitumour effect on distant lesions outside the primary irradiated area. Although immune checkpoint inhibitors have been widely studied for their potential to enhance the AE and improve patient outcomes, findings in cases of head and neck cancers remain limited. CASE PRESENTATION: We report the case of a 72-year-old man who experienced lung oligoprogression during nivolumab treatment for metastatic hypopharyngeal cancer. Stereotactic body radiotherapy (SBRT) was administered to one of the lung lesions, after which both irradiated and nonirradiated lesions regressed. Upon an 18-month follow-up period after SBRT, the patient showed no disease progression or toxicity, and continued receiving nivolumab therapy. CONCLUSION: The intent behind presenting this case report was to contribute to the accumulation of evidence regarding the AE in cases of head and neck cancer. S. Karger AG 2023-11-08 /pmc/articles/PMC10631779/ /pubmed/37946746 http://dx.doi.org/10.1159/000534609 Text en © 2023 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Endo, Masashi
Fukuda, Yukiko
Okada, Kouhei
Ogawa, Kazunari
Nakamura, Michiko
Takahashi, Satoru
Kawahara, Masahiro
Akahane, Keiko
Nagai, Yoshiaki
Yamaguchi, Hironori
Nishino, Hiroshi
Mori, Harushi
Shirai, Katsuyuki
Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
title Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
title_full Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
title_fullStr Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
title_full_unstemmed Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
title_short Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
title_sort abscopal effect after stereotactic body radiotherapy with nivolumab for lung metastasis of head and neck cancer: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631779/
https://www.ncbi.nlm.nih.gov/pubmed/37946746
http://dx.doi.org/10.1159/000534609
work_keys_str_mv AT endomasashi abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT fukudayukiko abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT okadakouhei abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT ogawakazunari abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT nakamuramichiko abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT takahashisatoru abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT kawaharamasahiro abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT akahanekeiko abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT nagaiyoshiaki abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT yamaguchihironori abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT nishinohiroshi abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT moriharushi abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport
AT shiraikatsuyuki abscopaleffectafterstereotacticbodyradiotherapywithnivolumabforlungmetastasisofheadandneckcanceracasereport